Staphyloma and Atrophy with Vitreoretinal tractionvu 62 foisOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.13 Avril 2026
Staphyloma and Atrophy with Vitreoretinal tractionvu 53 foisOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.13 Avril 2026
Staphyloma and Atrophy with Vitreoretinal tractionvu 52 foisOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.13 Avril 2026
Conversion to Wet AMD after Izervayvu 58 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 46 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 37 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 61 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 54 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 46 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 56 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 46 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 64 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 47 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 43 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 36 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 52 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 47 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 45 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 55 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Conversion to Wet AMD after Izervayvu 47 fois83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatment15 Mars 2026
Pattern Dystrophy with Collapsed Vitelliformvu 144 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 127 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 151 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 68 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 72 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 69 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 57 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 75 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 55 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 66 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 74 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 72 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 72 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 52 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 59 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 45 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 53 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 53 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 63 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 61 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 47 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 62 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 58 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 43 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 37 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Pattern Dystrophy with Collapsed Vitelliformvu 54 fois74 year old female with vision loss in eye with collapsed vitelliform lesion.18 Février 2026
Peripapillary CNVM No Treatmentvu 76 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 38 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 47 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 51 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 38 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 44 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 50 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 53 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 49 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 38 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 41 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 45 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 42 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 49 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 57 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 51 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 57 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 50 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 53 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 60 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 48 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 46 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 52 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 48 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 58 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 31 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 54 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 50 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Peripapillary CNVM No Treatmentvu 49 fois85 year old with peripapillary CNVM watched for many years.18 Février 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 55 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 64 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 61 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 66 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 70 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 73 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 64 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 72 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 61 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 52 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 79 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 64 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 75 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 56 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 69 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 71 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 59 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Post Anti-VEGF RPE Tear (Vabysmo)vu 66 fois87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/40011 Janvier 2026
Stable Myopic Tractional Maculopathyvu 66 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 61 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 69 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 66 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 62 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 70 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
Stable Myopic Tractional Maculopathyvu 62 fois73 year old female with mild vision loss from table myopic tractional maculopathy in the left eye23 Novembre 2025
